XML 86 R76.htm IDEA: XBRL DOCUMENT v3.22.2
Equity Incentive Plan - Summary of Company's Outstanding Restricted Stock (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   71,748
Expected future remaining compensation expense | $ $ 1,231 $ 1,231
Expected future compensation expense, restricted shares remaining vesting period   2 years 7 months 9 days
Restricted Shares Awarded on April 10, 2018 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   1,470
Date of Award   Apr. 10, 2018
Expected future remaining compensation expense | $ 15 $ 15
Expected future compensation expense, restricted shares remaining vesting period   6 months
Restricted Shares Awarded on March 14, 2019 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   4,034
Date of Award   Mar. 14, 2019
Expected future remaining compensation expense | $ 59 $ 59
Expected future compensation expense, restricted shares remaining vesting period   1 year 6 months
Restricted Shares Awarded on March 14, 2020 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   4,304
Date of Award   Mar. 14, 2020
Expected future remaining compensation expense | $ 42 $ 42
Expected future compensation expense, restricted shares remaining vesting period   6 months
Restricted Shares Awarded on March 14, 2020 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   6,951
Date of Award   Mar. 14, 2020
Expected future remaining compensation expense | $ 118 $ 118
Expected future compensation expense, restricted shares remaining vesting period   2 years 6 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   11,359
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 183 $ 183
Expected future compensation expense, restricted shares remaining vesting period   3 years 6 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   13,692
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 197 $ 197
Expected future compensation expense, restricted shares remaining vesting period   1 year 6 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   12,914
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ 282 $ 282
Expected future compensation expense, restricted shares remaining vesting period   4 years 6 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   17,024
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ $ 335 $ 335
Expected future compensation expense, restricted shares remaining vesting period   2 years 6 months
Restricted Stock [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Nonvested at beginning of period 76,530 69,840
Number of Restricted Shares, Granted 0 31,774
Number of Restricted Shares, Vested (2,644) (27,728)
Number of Restricted Shares, Forfeited (2,138) (2,138)
Number of Restricted Shares, Nonvested at end of period 71,748 71,748
Weighted Average Grant Date Fair Value, Nonvested at beginning of period | $ / shares $ 21.87 $ 20.14
Weighted Average Grant Date Fair Value, Granted | $ / shares 0 24.51
Weighted Average Grant Date Fair Value, Vested | $ / shares 21.57 24.28
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 21.99 21.99
Weighted Average Grant Date Fair Value, Nonvested at end of period | $ / shares $ 21.88 $ 21.88